GGrantIndex
Sort

40,608 grants matching prostate cancer

Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness

$344,109
Alan Pollack · University Of Miami School Of Medicine · U01 · FY2023 · CA

Leveraging PMN immune response to overcome ADT resistance in bone metastatic prostate cancer

$344,109
Grinu Mathew · University Of Nebraska Medical Center · R01 · FY2023 · CA

Novel Mechanisms of ROS/RNS Signaling Underlying Castration-Resistant Prostate Cancer Emergence and Progression

$344,109
Priyamvada Rai · University Of Miami School Of Medicine · R01 · FY2023 · CA

MR Signal Amplification for Receptor Imaging

$344,095
Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2008 · EB

Pharmcogenomic dissection of mTOR translational targets in prostate cancer

$344,062
Davide Ruggero · University Of California, San Francisco · R01 · FY2014 · CA

Hypoxia: Impact on Src Signaling and Prostate Cancer

$344,053
Dietmar W Siemann · University Of Florida · R01 · FY2018 · CA

Hypoxia: Impact on Src Signaling and Prostate Cancer

$344,053
Dietmar W Siemann · University Of Florida · R01 · FY2017 · CA

Hypoxia: Impact on Src Signaling and Prostate Cancer

$344,053
Dietmar W Siemann · University Of Florida · R01 · FY2020 · CA

PTEN and ontogenesis and tumor suppression

$344,028
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2008 · CA

Synthesis, StructUre and Replication of Carcirogen-Modified Oligonucleotides

$344,016
Carmelo J Rizzo · Vanderbilt University · R01 · FY2014 · ES

Epidemiologic and Basic Science in Cancer Prevention

$344,013
James Marshall · Roswell Park Cancer Institute Corp · R25 · FY2009 · CA

PRECLINICAL INVESTIGATIONS OF A NOVEL SMALL-MOLECULE RADIOSENSITIZER OF PROSTATE CANCER.

$344,001
University Of Miami · · FY2009 · Department of the Army

18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma

$343,987
David Michael Schuster · Emory University · R01 · FY2009 · CA

TRAF4 AND CASTRATION-RESISTANT PROSTATE CANCER

$343,983
Baylor College Of Medicine · · FY2015 · Department of the Army

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

$343,953
Peter H. Gann · University Of Illinois At Chicago · R01 · FY2011 · CA

Development of a targeted delivery platform for checkpoint inhibitors

$343,925
Kun Cheng · University Of Missouri Kansas City · R01 · FY2019 · CA

Novel targeted chemo/immunotherapy approach for localized and metastatic CaP

$343,925
Mohammad Saleem Bhat · University Of Minnesota · R01 · FY2019 · CA

Osteocytes in prostate cancer bone metastasis

$343,925
Evan Todd Keller · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Phosphorylation-dependent regulation of GLI transcription factors

$343,891
Scott Atwood · University Of California-Irvine · R01 · FY2019 · CA

Prostate Cancer Recurrence: models and mechanisms

$343,891
Sarki A. Abdulkadir · Vanderbilt University · R01 · FY2013 · CA

Exploiting Cancer Metabolism and Drug Efflux with Bystander-Assisted Immunotherapy

$343,885
Rock Mancini · Washington State University · R01 · FY2020 · CA

Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer

$343,883
Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · P50 · FY2021 · CA

Project 4: Targeting Genomic Instability in Distinct Subclasses of Prostate Cancer

$343,883
Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · P50 · FY2019 · CA

Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer

$343,882
David S. Rickman · Weill Medical Coll Of Cornell Univ · P50 · FY2021 · CA

Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer

$343,882
David S. Rickman · Weill Medical Coll Of Cornell Univ · P50 · FY2019 · CA